Co-Diagnostics Submits Co-Dx PCR Flu A/B & RSV Test for FDA Clearance
Co-Diagnostics submitted a dual 510(k) premarket notification and CLIA Waiver by Application to the FDA for its Co-Dx PCR Flu A/B & RSV multiplex respiratory test.
Co-Diagnostics submitted a dual 510(k) premarket notification and CLIA Waiver by Application to the FDA for its Co-Dx PCR Flu A/B & RSV multiplex respiratory test.
Researchers developed a system that redirects pre-existing antiviral signals to help the immune system recognize and attack cancer cells.
A study shows that a loss of immunity caused flu and RSV peaks to occur earlier in the season before returning to pre-pandemic patterns.
Specific host genotypes and sexes can cause influenza A viruses to gain virulence faster, potentially impacting the severity of flu outbreaks.
Enanta Pharma advanced zelicapavir into a registrational Phase 2b/3 clinical trial for adults at high risk of severe RSV outcomes.
Sam Neill, the actor famous for his role in the Jurassic Park films, died July 13th at the age of 78 due to pneumonia.